Key Record Dates
ClinicalTrials.gov Identifier: | NCT03927352 |
---|---|
Brief Title: | The Purpose of This Research Study is to Compare the Efficacy and Safety of SCT630 and Adalimumab (HUMIRA®) in Adults With Plaque Psoriasis |
First Submitted : | April 22, 2019 |
First Submitted that Met QC Criteria : | April 24, 2019 |
First Posted : | April 25, 2019 |
Last Update Submitted that Met QC Criteria : | January 26, 2021 |
Last Update Posted : | January 29, 2021 |